Cancer Types
CANCER TYPES
Breast Cancer
Extended Antibiotic Prophylaxis Not Beneficial After Postmastectomy Breast Reconstruction
Extended antibiotics do not reduce infection or reconstruction failure after postmastectomy breast reconstruction.
Testing for ESR1 Mutations Recommended in HR+, HER2- Metastatic Breast Cancer
Routine testing for ESR1 mutations should occur upon recurrence or progression of HR+, HER2- metastatic breast cancer, a guideline suggests.
Cervical Cancer
Smoking Cessation Intervention for Cervical Cancer Survivors Effective at 12 Months, Less So at 18 Months
The MAPS: Motivation and Problem Solving smoking cessation program was evaluated over 12 months, with a follow-up evaluation at 18 months, in women with cervical cancer.
Characteristics, Treatment Options for Patients With Advanced Gynecologic Cancers
A presentation at the 2023 ONA Summit reviewed diagnosis and treatment recommendations for uterine, ovarian, and endometrial cancers.
Colorectal Cancer
Prediagnostic Weight Loss Underestimates Risk for Colorectal Cancer
Association for high BMI and colorectal cancer risk most pronounced using BMI at least eight years before diagnosis.
Adding Bevacizumab to Trifluridine-Tipiracil Improves PFS, OS in Metastatic CRC
Adding bevacizumab to treatment with trifluridine-tipiracil improves outcomes in patients with refractory, metastatic colorectal cancer, a phase 3 study suggests.
Gastrointestinal Cancer
Adding Cixutumumab to Paclitaxel Does Not Improve Outcomes in Esophageal/GEJ Cancer
HIPEC With Mitomycin C Improves Locoregional Control in Colon Cancer
Genitourinary Cancer
Early Death May Be Common in Cancer Patients Taking Immune Checkpoint Inhibitors
AUA, SUO Issue New Guideline on Nonmetastatic UTUC
Gynecologic Cancer
No Benefit With Atezolizumab in BRCA1/2-Mutant or HRD Ovarian Cancer
Camonsertib-PARP Inhibitor Combos May Meet Unmet Need in Advanced Solid Tumors
Leukemia
Ianalumab, Ibrutinib Combination Promising in Chronic Lymphocytic Leukemia
Fixed Venetoclax Dosing May Not Be Feasible for All Patients With CLL
Liver Cancer
Results With Atezolizumab and Bevacizumab May Prove Practice-Changing for HCC
Immunotherapy Combo Reduces Risk of Cancer Recurrence in Early-Stage Liver Cancer
Lung Cancer
Cancer Death Rates Vary Across Congressional Districts
Surgical Treatment Provides Better Long-Term Survival for NSCLC
Lymphoma
CAR T-Cells May Be Safe in Non-Transplant Eligible Patients With Large B-Cell Lymphoma
High CMR Rates Seen With Nivolumab Plus Brentuximab Vedotin in CAYA Relapsed/Refractory Hodgkin Lymphoma
Melanoma
Cancer Patients With Diabetes May Have Worse Outcomes on ICIs
New Model Helps ID Melanoma Patients With Lymph Node Involvement
Multiple Myeloma
Aromatherapy Improved Management of Chemotherapy-Induced Nausea and Vomiting
Belantamab Mafodotin Deemed Safe, Effective in Real-World MM Population
Ovarian Cancer
Better Counseling, Uptake of BRCA1/2 Testing Needed in Hereditary Breast and Ovarian Cancer
Immunotherapy Improved Survival in Ovarian Cancer After Platinum Resistance
Pancreatic Cancer
Sex Hormones Linked to Risk of Gastrointestinal Cancers
NAFLD Linked to Higher Risk of Young-Onset Digestive Tract Cancers
Prostate Cancer
Enzalutamide Ups Metastasis-Free Survival in nmHSPC
Transgender Women May Be Underdiagnosed With Prostate Cancer
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Head and Neck Cancer
Loading... 
Loading...